MyoMap quantification of myocardial toxicity following concurrent chemoradiotherapy for esophageal carcinoma

Gary Liney

Crude rates of symptomatic cardiac toxicity in esophageal carcinoma are reportedly 10.8% [1]. Cardiac manifestations including clinical findings such as pericardial effusion, arrhythmia, ischemia and cardiomyopathy, typically occur between 4 to 24 months following thoracic radiation [2, 3].